ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 561,13
1,09%
Dow Jones
39 169,52
0,13%
DAX
18 290,66
0,31%
Brent Oil
86,49
1,62%
Bitcoin
63 087,99
0,78%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. bioAffinity Technologies Inc (BIAF)

  7. bioAffinity Technologies Inc (BIAF) Actualités

BIAF

bioAffinity Technologies (BIAF)

bioAffinity Technologies Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BIAF
DateHeureSourceTitreSymboleSociété
12/06/202414h00Business WirebioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung TestsNASDAQ:BIAFbioAffinity Technologies Inc
15/05/202415h15Business WirebioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory VolumesNASDAQ:BIAFbioAffinity Technologies Inc
02/05/202414h00Business WirebioAffinity Technologies News UpdateNASDAQ:BIAFbioAffinity Technologies Inc
24/04/202414h00Business WirebioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of GrowthNASDAQ:BIAFbioAffinity Technologies Inc
09/04/202414h00Business WirebioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer ScreeningNASDAQ:BIAFbioAffinity Technologies Inc
01/04/202415h49Business WirebioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:BIAFbioAffinity Technologies Inc
08/03/202423h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIAFbioAffinity Technologies Inc
08/03/202419h15PR Newswire (US)Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
08/03/202418h45Business WirebioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
08/03/202418h18Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BIAFbioAffinity Technologies Inc
06/03/202416h45PR Newswire (US)WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
06/03/202415h46Business WirebioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
05/03/202414h00Business WirebioAffinity Technologies Reports Accelerating Sales Growth of CyPath® LungNASDAQ:BIAFbioAffinity Technologies Inc
06/02/202414h00Business WireMedical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical PracticeNASDAQ:BIAFbioAffinity Technologies Inc
02/02/202422h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
30/01/202414h00Business WirebioAffinity Technologies In The NewsNASDAQ:BIAFbioAffinity Technologies Inc
23/01/202414h00Business WirebioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of CancerNASDAQ:BIAFbioAffinity Technologies Inc
08/01/202414h00Business WirebioAffinity Technologies In the NewsNASDAQ:BIAFbioAffinity Technologies Inc
08/12/202322h06Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
05/12/202314h00Business WirebioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of DirectorsNASDAQ:BIAFbioAffinity Technologies Inc
30/11/202314h00Business WireCMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024NASDAQ:BIAFbioAffinity Technologies Inc
28/11/202314h00Business WirebioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology PostNASDAQ:BIAFbioAffinity Technologies Inc
28/11/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BIAFbioAffinity Technologies Inc
16/11/202323h23Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BIAFbioAffinity Technologies Inc
15/11/202314h00Business WirebioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer ScreeningNASDAQ:BIAFbioAffinity Technologies Inc
14/11/202322h01Business WirebioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:BIAFbioAffinity Technologies Inc
14/11/202321h11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BIAFbioAffinity Technologies Inc
06/11/202314h00Business WirebioAffinity Technologies Names Dallas J. Coleman as National Director of SalesNASDAQ:BIAFbioAffinity Technologies Inc
03/11/202321h49Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:BIAFbioAffinity Technologies Inc
03/11/202321h45Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BIAFbioAffinity Technologies Inc
 Showing the most relevant articles for your search:NASDAQ:BIAF

Dernières Valeurs Consultées

FTSE
UKX
FTSE 100
NASDAQ
MSFT
Microsoft
EU
MC
Lvmh Moet Hennessy Louis...
EU
VK
Vallourec
EU
PX4
SBF 120
NASDAQ
NVDA
NVIDIA
EU
BEL20
Bel 20
USI
USTECH100
US Tech 100
EU
LR
Legrand
NYSE
KO
Coca Cola
EU
BN
Danone
EU
AF
Air FranceKLM
EU
CS
Axa
NYSE
JPM
JP Morgan Chase
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés